OMASS THERAPEUTICS LIMITED - OXFORD
Company Profile | Company Filings |
Overview
OMASS THERAPEUTICS LIMITED is a Private Limited Company from OXFORD ENGLAND and has the status: Active.
OMASS THERAPEUTICS LIMITED was incorporated 8 years ago on 26/02/2016 and has the registered number: 10028228. The accounts status is SMALL and accounts are next due on 30/09/2024.
OMASS THERAPEUTICS LIMITED was incorporated 8 years ago on 26/02/2016 and has the registered number: 10028228. The accounts status is SMALL and accounts are next due on 30/09/2024.
OMASS THERAPEUTICS LIMITED - OXFORD
This company is listed in the following categories:
72110 - Research and experimental development on biotechnology
72110 - Research and experimental development on biotechnology
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
31 / 12 | 31/12/2022 | 30/09/2024 |
Registered Office
BUILDING 4000 JOHN SMITH DRIVE
OXFORD
OX4 2GX
ENGLAND
This Company Originates in : United Kingdom
Previous trading names include:
OMASS TECHNOLOGIES LIMITED (until 21/11/2018)
OMASS TECHNOLOGIES LIMITED (until 21/11/2018)
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
21/03/2023 | 04/04/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR EDWARD ELIOT HODGKIN | Aug 1963 | British | Director | 2017-05-24 | CURRENT |
DR CHRISTOPHER PHILIP ASHTON | Feb 1960 | British | Director | 2020-10-14 | CURRENT |
MR JONATHAN DEANE MONTAGU DAOUST | Oct 1975 | British | Director | 2019-05-30 | CURRENT |
DR MAGDALENA ANNA JONIKAS | Apr 1984 | British | Director | 2018-06-29 | CURRENT |
MS DIANA BERNSTEIN | Oct 1986 | American | Director | 2022-04-19 | CURRENT |
MR JAMES ARTHUR GERAGHTY | Jul 1954 | American | Director | 2023-05-09 | CURRENT |
MRS NATHALIE MARIE BERTHE MICHELLE FRANCHIMONT | Oct 1965 | Belgian | Director | 2020-07-23 | CURRENT |
MS ROSAMOND MARGARET CHEVALLIER DEEGAN | Feb 1973 | British | Director | 2019-05-30 | CURRENT |
PHD LAIA CRESPO-MARTIN | May 1974 | Spanish | Director | 2022-04-19 | CURRENT |
DR (PHD) SCOTT BILLER | Dec 1955 | American | Director | 2022-04-19 | CURRENT |
PROFESSOR WILLIAM GRAHAM RICHARDS | Oct 1939 | British | Director | 2016-04-01 UNTIL 2018-06-28 | RESIGNED |
MR DAVID JOHN BRISTER | Sep 1962 | British | Director | 2017-05-24 UNTIL 2018-06-28 | RESIGNED |
DOCTOR JONATHAN HOPPER | May 1984 | British | Director | 2016-03-22 UNTIL 2019-05-30 | RESIGNED |
MR ROGER JAMES HUMM | Feb 1959 | British | Director | 2016-02-26 UNTIL 2018-03-31 | RESIGNED |
MR LACHLAN MACKINNON | Apr 1993 | British | Director | 2016-03-24 UNTIL 2020-10-14 | RESIGNED |
PROFESSOR DAME CAROL ROBINSON | Apr 1956 | British | Director | 2016-03-22 UNTIL 2022-04-19 | RESIGNED |
MR ROGER JAMES HUMM | Secretary | 2016-02-26 UNTIL 2018-03-31 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Syncona Limited | 2018-09-11 | St Peter Port |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
Oxford Science Enterprises Plc | 2018-09-11 | Oxford |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
|
Oxford Sciences Innovation Plc | 2016-04-06 - 2018-09-11 | Oxford |
Ownership of shares 25 to 50 percent Voting rights 25 to 50 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
OMASS THERAPEUTICS LIMITED | 2021-05-14 | 31-12-2020 | £10,057,644 Cash £13,891,798 equity |